HUE058751T2 - In vitro method for identifying colorectal adenomas or colorectal cancer - Google Patents
In vitro method for identifying colorectal adenomas or colorectal cancerInfo
- Publication number
- HUE058751T2 HUE058751T2 HUE17825751A HUE17825751A HUE058751T2 HU E058751 T2 HUE058751 T2 HU E058751T2 HU E17825751 A HUE17825751 A HU E17825751A HU E17825751 A HUE17825751 A HU E17825751A HU E058751 T2 HUE058751 T2 HU E058751T2
- Authority
- HU
- Hungary
- Prior art keywords
- colorectal
- identifying
- vitro method
- adenomas
- colorectal cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16382567.2A EP3327135A1 (en) | 2016-11-28 | 2016-11-28 | In vitro method for identifying colorectal adenomas or colorectal cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE058751T2 true HUE058751T2 (en) | 2022-09-28 |
Family
ID=57544368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE17825751A HUE058751T2 (en) | 2016-11-28 | 2017-11-27 | In vitro method for identifying colorectal adenomas or colorectal cancer |
Country Status (8)
Country | Link |
---|---|
US (2) | US20190316212A1 (en) |
EP (2) | EP3327135A1 (en) |
DK (1) | DK3545109T3 (en) |
ES (1) | ES2909895T3 (en) |
HU (1) | HUE058751T2 (en) |
PL (1) | PL3545109T3 (en) |
PT (1) | PT3545109T (en) |
WO (1) | WO2018096154A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4130296A1 (en) * | 2021-08-03 | 2023-02-08 | Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg | Cancer prediction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102933719B (en) * | 2009-12-24 | 2015-05-06 | 复旦大学 | Compositions and methods for microrna expession profiling in plasma of colorectal cancer |
NO3051026T3 (en) * | 2011-10-21 | 2018-07-28 |
-
2016
- 2016-11-28 EP EP16382567.2A patent/EP3327135A1/en not_active Withdrawn
-
2017
- 2017-11-27 EP EP17825751.5A patent/EP3545109B1/en active Active
- 2017-11-27 PL PL17825751T patent/PL3545109T3/en unknown
- 2017-11-27 HU HUE17825751A patent/HUE058751T2/en unknown
- 2017-11-27 WO PCT/EP2017/080560 patent/WO2018096154A1/en unknown
- 2017-11-27 PT PT178257515T patent/PT3545109T/en unknown
- 2017-11-27 US US16/464,674 patent/US20190316212A1/en not_active Abandoned
- 2017-11-27 ES ES17825751T patent/ES2909895T3/en active Active
- 2017-11-27 DK DK17825751.5T patent/DK3545109T3/en active
-
2022
- 2022-01-06 US US17/570,221 patent/US20220220562A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
PT3545109T (en) | 2022-04-14 |
EP3545109A1 (en) | 2019-10-02 |
PL3545109T3 (en) | 2022-05-02 |
DK3545109T3 (en) | 2022-04-04 |
ES2909895T3 (en) | 2022-05-10 |
EP3327135A1 (en) | 2018-05-30 |
WO2018096154A1 (en) | 2018-05-31 |
EP3545109B1 (en) | 2022-01-05 |
US20190316212A1 (en) | 2019-10-17 |
US20220220562A1 (en) | 2022-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248285A1 (en) | Method and system for determining cancer status | |
HK1251407A1 (en) | Methods for treating cancer | |
IL254760A (en) | Method for treating cancer | |
HK1256793A1 (en) | Compounds and methods useful for treating or preventing hematological cancers | |
HK1249469A1 (en) | Methods for treating cancer with rorgamma inhibitors | |
HK1255533A1 (en) | Protein biomarker panels for detecting colorectal cancer and advanced adenoma | |
IL257691A (en) | Method for treating cancer | |
HK1258924A1 (en) | Methods and composition for determining ph | |
IL267315A (en) | Methods of determining colorectal cancer status in an individual | |
HK1250944A1 (en) | Methods for treating cancer | |
EP3271483A4 (en) | Methods and materials for assessing and treating cancer | |
EP3349011A4 (en) | Liver cancer test method | |
IL264359A (en) | Combination test for colorectal cancer | |
HK1250942A1 (en) | Methods for treating cancer | |
SG11201702076WA (en) | Cancer evaluation method and cancer evaluation system | |
HK1250943A1 (en) | Methods for treating cancer | |
EP3282014A4 (en) | Cancer cell-specific anti-podocalyxin antibody and method for producing same | |
EP3134545A4 (en) | Method and biomarker for detecting cancer | |
EP3184635A4 (en) | Cancer marker and cancer determination method | |
IL257514A (en) | Cancer detection method | |
PL3545109T3 (en) | In vitro method for identifying colorectal adenomas or colorectal cancer | |
EP3258923A4 (en) | Methods and materials for assessing chemotherapy responsiveness and treating cancer | |
GB201411393D0 (en) | Agents and methods for determining colorectal cancer status | |
GB201604809D0 (en) | Method for detecting cancer | |
GB201604813D0 (en) | Methods for detecting cancer |